{"id":"https://openalex.org/W2791781256","doi":"https://doi.org/10.3389/fimmu.2018.00237","title":"Herpesviruses in the Activated Phosphatidylinositol-3-Kinase-\u03b4 Syndrome","display_name":"Herpesviruses in the Activated Phosphatidylinositol-3-Kinase-\u03b4 Syndrome","publication_year":2018,"publication_date":"2018-02-23","ids":{"openalex":"https://openalex.org/W2791781256","doi":"https://doi.org/10.3389/fimmu.2018.00237","mag":"2791781256","pmid":"https://pubmed.ncbi.nlm.nih.gov/29599765","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5863522"},"language":"en","primary_location":{"id":"doi:10.3389/fimmu.2018.00237","doi":"https://doi.org/10.3389/fimmu.2018.00237","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2018.00237","pdf_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2018.00237/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2018.00237/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024634769","display_name":"Jeffrey I. Cohen","orcid":"https://orcid.org/0000-0003-0238-7176","observed_orcids":["https://orcid.org/0000-0003-0238-7176"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210134534","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210134534"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Jeffrey I. Cohen","raw_affiliation_strings":["Medical Virology Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Virology Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210134534"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5024634769"],"corresponding_institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210134534"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.3629,"has_fulltext":true,"cited_by_count":35,"citation_normalized_percentile":{"value":0.30610687,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"9","issue":null,"first_page":"237","last_page":"237"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11725","display_name":"Immunodeficiency and Autoimmune Disorders","score":0.8378999829292297,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11725","display_name":"Immunodeficiency and Autoimmune Disorders","score":0.8378999829292297,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10981","display_name":"Cytomegalovirus and herpesvirus research","score":0.07819999754428864,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10625","display_name":"Herpesvirus Infections and Treatments","score":0.046799998730421066,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pi3k-akt-signaling","display_name":"PI3K/Akt signaling","score":0.7870000004768372},{"id":"https://openalex.org/keywords/p110delta","display_name":"p110\u03b4","score":0.7279999852180481},{"id":"https://openalex.org/keywords/p85-regulatory-subunit","display_name":"p85 regulatory subunit","score":0.8840000033378601},{"id":"https://openalex.org/keywords/herpesvirus-infection","display_name":"herpesvirus infection","score":0.7770000100135803},{"id":"https://openalex.org/keywords/epstein-barr-virus","display_name":"Epstein-Barr virus","score":0.9710000157356262},{"id":"https://openalex.org/keywords/cytomegalovirus","display_name":"cytomegalovirus","score":0.9959999918937683},{"id":"https://openalex.org/keywords/lymphoproliferative-disorders","display_name":"lymphoproliferative disorders","score":0.7120000123977661},{"id":"https://openalex.org/keywords/molluscum-contagiosum","display_name":"molluscum contagiosum","score":0.8029999732971191},{"id":"https://openalex.org/keywords/cd8-t-cell-differentiation","display_name":"CD8+ T cell differentiation","score":0.7390000224113464},{"id":"https://openalex.org/keywords/immunodeficiency","display_name":"immunodeficiency","score":0.6129999756813049},{"id":"https://openalex.org/keywords/lymphoproliferation","display_name":"lymphoproliferation","score":0.593999981880188}],"concepts":[{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.6696013808250427},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5531684756278992},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.5488130450248718},{"id":"https://openalex.org/C2781196997","wikidata":"https://www.wikidata.org/wiki/Q655331","display_name":"Herpes simplex virus","level":3,"score":0.4759763777256012},{"id":"https://openalex.org/C2777732132","wikidata":"https://www.wikidata.org/wiki/Q6946","display_name":"Cytomegalovirus","level":5,"score":0.47240036725997925},{"id":"https://openalex.org/C2776185481","wikidata":"https://www.wikidata.org/wiki/Q1425304","display_name":"Viremia","level":3,"score":0.4669761657714844},{"id":"https://openalex.org/C2776159415","wikidata":"https://www.wikidata.org/wiki/Q6868","display_name":"Varicella zoster virus","level":3,"score":0.46667706966400146},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.45708465576171875},{"id":"https://openalex.org/C2777016524","wikidata":"https://www.wikidata.org/wiki/Q630552","display_name":"Retinitis","level":4,"score":0.417338490486145},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.40448540449142456},{"id":"https://openalex.org/C2776409557","wikidata":"https://www.wikidata.org/wiki/Q149348","display_name":"Herpesviridae","level":4,"score":0.3733571469783783},{"id":"https://openalex.org/C2779820661","wikidata":"https://www.wikidata.org/wiki/Q6929","display_name":"Human cytomegalovirus","level":3,"score":0.307162344455719},{"id":"https://openalex.org/C2780727368","wikidata":"https://www.wikidata.org/wiki/Q1928978","display_name":"Viral disease","level":3,"score":0.15770813822746277}],"mesh":[{"descriptor_ui":"D000073659","descriptor_name":"Gain of Function Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000081207","descriptor_name":"Primary Immunodeficiency Diseases","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003586","descriptor_name":"Cytomegalovirus Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D003586","descriptor_name":"Cytomegalovirus Infections","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D003586","descriptor_name":"Cytomegalovirus Infections","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D003586","descriptor_name":"Cytomegalovirus Infections","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D003587","descriptor_name":"Cytomegalovirus","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D003587","descriptor_name":"Cytomegalovirus","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":false},{"descriptor_ui":"D004854","descriptor_name":"Herpesvirus 4, Human","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D004854","descriptor_name":"Herpesvirus 4, Human","qualifier_ui":"Q000302","qualifier_name":"isolation & purification","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007153","descriptor_name":"Immunologic Deficiency Syndromes","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D007153","descriptor_name":"Immunologic Deficiency Syndromes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D007153","descriptor_name":"Immunologic Deficiency Syndromes","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014766","descriptor_name":"Viremia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D014766","descriptor_name":"Viremia","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D014766","descriptor_name":"Viremia","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D014766","descriptor_name":"Viremia","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D019869","descriptor_name":"Phosphatidylinositol 3-Kinases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D019869","descriptor_name":"Phosphatidylinositol 3-Kinases","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D019869","descriptor_name":"Phosphatidylinositol 3-Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D020022","descriptor_name":"Genetic Predisposition to Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020031","descriptor_name":"Epstein-Barr Virus Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D020031","descriptor_name":"Epstein-Barr Virus Infections","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D020031","descriptor_name":"Epstein-Barr Virus Infections","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D020031","descriptor_name":"Epstein-Barr Virus Infections","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D051057","descriptor_name":"Proto-Oncogene Proteins c-akt","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D051057","descriptor_name":"Proto-Oncogene Proteins c-akt","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D058534","descriptor_name":"Class I Phosphatidylinositol 3-Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D058534","descriptor_name":"Class I Phosphatidylinositol 3-Kinases","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D058534","descriptor_name":"Class I Phosphatidylinositol 3-Kinases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D058534","descriptor_name":"Class I Phosphatidylinositol 3-Kinases","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D058534","descriptor_name":"Class I Phosphatidylinositol 3-Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D058543","descriptor_name":"Class Ia Phosphatidylinositol 3-Kinase","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.3389/fimmu.2018.00237","doi":"https://doi.org/10.3389/fimmu.2018.00237","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2018.00237","pdf_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2018.00237/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:5863522","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5863522","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Front Immunol","raw_type":"Text"},{"id":"pmid:29599765","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29599765","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in immunology","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:b73f1beeda0749eb89c8d631a0fffce0","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/b73f1beeda0749eb89c8d631a0fffce0","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Immunology, Vol 9 (2018)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fimmu.2018.00237","doi":"https://doi.org/10.3389/fimmu.2018.00237","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2018.00237","pdf_url":"https://www.frontiersin.org/articles/10.3389/fimmu.2018.00237/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320309123","display_name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2791781256.pdf","grobid_xml":"https://content.openalex.org/works/W2791781256.grobid-xml"},"referenced_works_count":63,"referenced_works":["https://openalex.org/W102230927","https://openalex.org/W1483350500","https://openalex.org/W1851143609","https://openalex.org/W1969530971","https://openalex.org/W1970978678","https://openalex.org/W1972946600","https://openalex.org/W1976300856","https://openalex.org/W1976789091","https://openalex.org/W1981685888","https://openalex.org/W2009056249","https://openalex.org/W2009438033","https://openalex.org/W2011960178","https://openalex.org/W2016970796","https://openalex.org/W2020639478","https://openalex.org/W2022773122","https://openalex.org/W2024460705","https://openalex.org/W2028165101","https://openalex.org/W2028483614","https://openalex.org/W2030277142","https://openalex.org/W2030604587","https://openalex.org/W2033505817","https://openalex.org/W2038713701","https://openalex.org/W2043833032","https://openalex.org/W2052791774","https://openalex.org/W2055630249","https://openalex.org/W2058262035","https://openalex.org/W2060519150","https://openalex.org/W2060698197","https://openalex.org/W2061479893","https://openalex.org/W2064048288","https://openalex.org/W2072765132","https://openalex.org/W2077349622","https://openalex.org/W2082595913","https://openalex.org/W2102578228","https://openalex.org/W2108473200","https://openalex.org/W2109125050","https://openalex.org/W2112757981","https://openalex.org/W2116403673","https://openalex.org/W2117191987","https://openalex.org/W2120239952","https://openalex.org/W2122952039","https://openalex.org/W2138355348","https://openalex.org/W2144520068","https://openalex.org/W2150357985","https://openalex.org/W2157582689","https://openalex.org/W2200215774","https://openalex.org/W2213308312","https://openalex.org/W2213397720","https://openalex.org/W2222815228","https://openalex.org/W2344083562","https://openalex.org/W2397769881","https://openalex.org/W2513184125","https://openalex.org/W2529584177","https://openalex.org/W2586225347","https://openalex.org/W2595059891","https://openalex.org/W2605742765","https://openalex.org/W2607508743","https://openalex.org/W2617440710","https://openalex.org/W2734712923","https://openalex.org/W2744377419","https://openalex.org/W2751615712","https://openalex.org/W2761652334","https://openalex.org/W6678263823"],"related_works":["https://openalex.org/W2028483614","https://openalex.org/W2009438033","https://openalex.org/W7127079238","https://openalex.org/W3192860174","https://openalex.org/W2072765132","https://openalex.org/W3190483459","https://openalex.org/W2887221391","https://openalex.org/W2081563789","https://openalex.org/W3164071283","https://openalex.org/W1993926445"],"abstract_inverted_index":{"The":[0,66,139],"phosphatidylinositol-3-kinase":[1],"(PI3K)/Akt":[2],"pathway":[3],"is":[4,148],"important":[5],"for":[6],"multiple":[7],"stages":[8],"of":[9,28,35,48,155,165],"herpesvirus":[10,107],"replication":[11],"including":[12],"virus":[13,64,69,75,137,143],"entry,":[14],"replication,":[15],"latency,":[16],"and":[17,54,77,116,133,161],"reactivation.":[18],"Recently,":[19],"patients":[20,41,80,96,147],"with":[21,46,52,83,100,120],"gain-of-function":[22],"mutations":[23],"in":[24,31,145],"the":[25,32,121],"p110\u03b4-catalytic":[26],"subunit":[27,34],"PI3K":[29,36,45],"or":[30,92,104],"p85-regulatory":[33],"have":[37,42,56,97,109,127],"been":[38,98],"reported.":[39],"These":[40],"constitutively":[43],"active":[44],"hyperactivation":[47],"Akt.":[49],"They":[50],"present":[51,82],"lymphoproliferation":[53],"often":[55,81],"infections,":[57],"particularly":[58],"recurrent":[59,114],"respiratory":[60],"infections":[61,70,108,126,144],"and/or":[62,86],"severe":[63,131],"infections.":[65],"most":[67],"frequent":[68],"are":[71],"due":[72,150],"to":[73,142,151],"Epstein-Barr":[74],"(EBV)":[76],"cytomegalovirus":[78],"(CMV);":[79],"persistent":[84],"EBV":[85,89],"CMV":[87,93,101],"viremia,":[88,130],"lymphoproliferative":[90],"disease,":[91],"lymphadenitis.":[94],"No":[95],"reported":[99],"pneumonia,":[102,113],"colitis,":[103],"retinitis.":[105],"Other":[106],"included":[110,128],"herpes":[111],"simplex":[112],"zoster,":[115],"varicella":[117,122],"after":[118],"vaccination":[119],"vaccine.":[123],"Additional":[124],"viral":[125],"adenovirus":[129],"warts,":[132],"extensive":[134],"Molluscum":[135],"contagiosum":[136],"infection.":[138],"increased":[140,163],"susceptibility":[141],"these":[146],"likely":[149],"a":[152],"reduced":[153],"number":[154,164],"long-lived":[156],"memory":[157],"CD8":[158,169],"T":[159,170],"cells":[160],"an":[162],"terminally":[166],"differentiated":[167],"effector":[168],"cells.":[171]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":8},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-05T12:25:35.769452","created_date":"2018-03-29T00:00:00"}